Chronic kidney disease patients with hypertriglyceridemia
Conditions
Interventions
None listed
Sponsors
MIMA AKIRA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. serum TG more or 150 mg/dL 2. eGFR less than 20mL/min/1.73m2
Exclusion criteria
Exclusion criteria: (1) Patients with any of the following Patients with malignant tumors Patients on immunosuppressive drugs Patients with contraindications to pemafibrate (2) Other research subjects who are judged by the principal investigator or physician in charge to be unsuitable for the safe conduct of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of TG concentrations achieving <150 mg/dL at 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| TG, LDL-C, HDL-C, TC, nonHDL-C, RLP-C, sdLDL-C, AST, ALT, g-GTP, ALP, creatinine, eGFR, BUN, cystatin C, blood glucose, HbA1c, insulin, HOMA-IR, GA, BNP, NT-proBNP, CPK, uric acid, Total protein, albumin, RBC, WBC, platelet count, hemoglobin, hematocrit, TNF-a, IL-6, hsCRP, FABP, urine NAG, urine b2 myoglobin, urine albumin, urine protein, urine creatinine, UACR, UPCR adverse events | — |
Contacts
Public ContactAKIRA MIMA
Nagai Hospital
Outcome results
None listed